Global Animal Drug Compounding Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Animal Drug Compounding Market is presumed to reach the market size of nearly USD 4.21 Billion by 2032 from USD 1.98 Billion in 2023 with a CAGR of 8.73% under the study period 2024-2032.

Animal drug compounding is the process of consolidating, blending or modifying mixtures to make a medication customized to the needs of an individual animal or a small group of animals. Pharmacists or veterinarians typically make them. Animal drug compounding does not require FDA approval to demonstrate safety and efficiency unless compounding raw material or active ingredient is an FDA-approved drug. Preparing an oral paste or suspension from crushed tablets, mixing two injectable medications, or adding flavoring to a drug are typical examples of animal drug compounding.

MARKET DYNAMICS

Spurring animal disease burden, increased humanization of pets, and rising adoption of animals in developed and developing nations are likely to boost the global animal drug compounding market. The increasing cost of branded prescription equivalents, inadequate accessibility to drugs, and the growing influx of medical information over the internet are other factors augmenting the market growth. Key market players are focused on expanding their portfolios by delivering substitute vet compounding solutions to meet the desired needs of animals. Key companies are also consolidating with consulting veterinarians to provide up-to-date information about common compounds. However, concerns about safety, quality, and effectiveness and the absence or lack of trained and skilled medical professionals are factors restraining demand for animal drug compounding.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Animal Drug Compounding. The growth and trends of Animal Drug Compounding industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Animal Drug Compounding market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Animal Type

Companion Animals (Dogs, Cats, Others)
Livestock Animals

By Product

Anti-Infective Agents
Anti-Inflammatory Agents
Hormones & Substitutes
CNS Agents
Others

By Route of Administration

Oral
Injectable
Topical
Others

By Dosage Form

Suspensions
Solutions
Capsules

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Animal Drug Compounding market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Animal Drug Compounding market include Wedgewood Pharmacy, Vimian, Pharmaca., Akina Animal Health, Triangle Compounding., Davis Islands Pharmacy And Compounding Lab, Custom Med Compounding Pharmacy, Central Compounding Center South., Wellness Pharmacy Of Cary., Miller'S Pharmacy. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11215051

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ANIMAL DRUG COMPOUNDING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Animal Type
- 3.7.2 Market Attractiveness Analysis By Product
- 3.7.3 Market Attractiveness Analysis By Route of Administration
- 3.7.4 Market Attractiveness Analysis By Dosage Form
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY ANIMAL TYPE

5.1. Overview By Animal Type
5.2. Historical and Forecast Data Analysis By Animal Type
5.3. Companion Animals (Dogs, Cats, Others) Historic and Forecast Sales By Regions
5.4. Livestock Animals Historic and Forecast Sales By Regions

6. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY PRODUCT

6.1. Overview By Product
6.2. Historical and Forecast Data Analysis By Product
6.3. Anti-Infective Agents Historic and Forecast Sales By Regions
6.4. Anti-Inflammatory Agents Historic and Forecast Sales By Regions
6.5. Hormones & Substitutes Historic and Forecast Sales By Regions
6.6. CNS Agents Historic and Forecast Sales By Regions
6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

7.1. Overview By Route of Administration
7.2. Historical and Forecast Data Analysis By Route of Administration
7.3. Oral Historic and Forecast Sales By Regions
7.4. Injectable Historic and Forecast Sales By Regions
7.5. Topical Historic and Forecast Sales By Regions
7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY DOSAGE FORM

8.1. Overview By Dosage Form
8.2. Historical and Forecast Data Analysis By Dosage Form
8.3. Suspensions Historic and Forecast Sales By Regions
8.4. Solutions Historic and Forecast Sales By Regions
8.5. Capsules Historic and Forecast Sales By Regions

9. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ANIMAL DRUG COMPOUNDING COMPANIES

10.1. Animal Drug Compounding Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF ANIMAL DRUG COMPOUNDING INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Wedgewood Pharmacy
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Vimian
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Pharmaca.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Akina Animal Health
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Triangle Compounding.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Davis Islands Pharmacy And Compounding Lab
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Custom Med Compounding Pharmacy
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Central Compounding Center South.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Wellness Pharmacy Of Cary.
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Miller'S Pharmacy
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies